Amerise Biosciences Ltd
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|
| Revenue | 0.08 | 0.04 | 0.07 |
| Operating Expense | 0.02 | 0.04 | 0.11 |
| Net Profit | 0.06 | 0.01 | -0.04 |
| Net Profit Margin | 75% | 25% | -57.14% |
| Earning Per Share | 0.01 | 0 | -0.01 |
| EBIDTA | 0.06 | 0.01 | -0.04 |
| Effective Tax Rate | 0% | 0% | -0% |
Particulars
Mar 2026
Revenue0.08
Operating Expense0.02
Net Profit0.06
Net Profit Margin75
Earning Per Share0.01
EBIDTA0.06
Effective Tax Rate0
